These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3291246)

  • 1. Pediatric cadaveric kidneys in recipients treated with cyclosporine.
    Smith AY; Kerman RH; Van Buren CT; Lewis RM; Kahan BD
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):215-21. PubMed ID: 3291246
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term results in cadaveric renal transplantation under cyclosporine therapy.
    Land W; Schneeberger H; Schleibner S; Illner WD; Abendroth D; Hillebrand G; Gokel JM; Albert E; Fornara P
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1244-6. PubMed ID: 1989200
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of blood transfusions and HLA on cyclosporine-treated renal transplant recipients.
    Kerman RH; Van Buren CT; Lewis RM; Kahan BD
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):264-9. PubMed ID: 3291254
    [No Abstract]   [Full Text] [Related]  

  • 4. The outcome of repeat cadaveric kidney transplants in recipients managed with cyclosporine.
    Smith AY; Van Buren CT; Lewis RM; Kerman RH; Welsh M; Kahan BD
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):180-93. PubMed ID: 3291239
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk factors for cadaveric donor allograft survival in cyclosporine-prednisone-treated recipients.
    Kahan BD; Mickey R; Flechner SM; Lorber MI; Wideman CA; Kerman RH; Terasaki P; Van Buren CT
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1835-8. PubMed ID: 3547890
    [No Abstract]   [Full Text] [Related]  

  • 6. Factors influencing the improvement in cadaveric renal transplant survival in pediatric recipients.
    Ettenger RB; Rosenthal JT; Marik J; Forsythe S; Malekzadeh MH; Kamil E; Salusky IB; Fine RN
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1693-5. PubMed ID: 2652554
    [No Abstract]   [Full Text] [Related]  

  • 7. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The UNOS scientific renal transplant registry. United Network for Organ Sharing.
    Cecka JM; Terasaki PI
    Clin Transpl; 1995; ():1-18. PubMed ID: 8794251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical management of immunosuppressive therapy for cyclosporine-treated recipients of cadaver kidney transplants at one to six months.
    Feduska NJ; Melzer J; Amend WJ; Vincenti F; Tomlanovich S; Salvatierra O
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):136-40. PubMed ID: 3515681
    [No Abstract]   [Full Text] [Related]  

  • 10. Transplantation of pediatric cadaver kidneys into adult recipients.
    Gourlay W; Stothers L; McLoughlin MG; Manson AD; Keown P
    J Urol; 1995 Feb; 153(2):322-5 6. PubMed ID: 7815572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved results using pediatric cadaver donor kidneys with cyclosporine immunosuppression.
    Hayes JM; Novick AC; Steinmuller DR; Streem SB; Hodge EE; Bretan PN; Cunningham R; Graneto D
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):209-14. PubMed ID: 3291245
    [No Abstract]   [Full Text] [Related]  

  • 12. Is cyclosporine indicated in HLA-identical renal transplant recipients?
    Sumrani N; Delaney V; Ding Z; Davis R; Butt K; Hong J
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1239-40. PubMed ID: 1989199
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of the "NIMA effect" in renal transplantation. Collaborative Transplant Study.
    Opelz G
    Clin Transpl; 1990; ():63-7. PubMed ID: 2103176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation of kidneys from living related donors. Comparison with cadaveric kidney transplantation.
    Thomson NM; Atkins RC; Scott DF; Marshall VC; McGinley E; Holdsworth SR; Ironside W
    Med J Aust; 1983 Dec 10-24; 2(12):609-12. PubMed ID: 6366497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of HLA matching and pretransplant blood transfusions in cyclosporine-treated recipients of cadaveric renal allografts: 2- to 3-year results.
    Lundgren G; Albrechtsen D; Brynger H; Flatmark A; Frödin L; Gäbel H; Lindholm A; Maurer W; Möller E; Persson H
    Transplant Proc; 1987 Oct; 19(5):3614-8. PubMed ID: 3313870
    [No Abstract]   [Full Text] [Related]  

  • 16. No effect of blood transfusions or HLA matching on renal graft success rate in recipients treated with cyclosporine-prednisolone or cyclosporine-azathioprine-prednisolone: the Scandinavian experience.
    Brynger H; Persson H; Flatmark A; Albrechtsen D; Frödin L; Tufvesson G; Gäbel H; Weibull H; Möller E; Lundgren G
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):261-3. PubMed ID: 3291253
    [No Abstract]   [Full Text] [Related]  

  • 17. The UNOS Scientific Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 1999; ():1-21. PubMed ID: 11038622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cadaveric renal transplantation in Manitoba--the last eight years.
    Jeffery JR; Downs A; Lye C; McKenzie JK; Paquin W; Ramsey E; Rush D; Thomson AE
    Transplant Proc; 1984 Aug; 16(4):1073-5. PubMed ID: 6380053
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of HLA matching in cadaver renal transplants.
    Najarian JS; Migliori RJ; Simmons RL; Ascher NL; Payne WD; Dunn D; Sutherland DE; Fryd DS
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):249-56. PubMed ID: 3291251
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term impact of HLA matching on kidney graft survival in cyclosporine-treated recipients.
    Opelz G; Schwarz V; Engelmann A; Back D; Wilk M; Keppel E
    Transplant Proc; 1991 Feb; 23(1 Pt 1):373-5. PubMed ID: 1990556
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.